arrow
C

Chris Gast

Northumbria University
H指数:47
被引数:7,518

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct gastrointestinal symptom phenotypes in adults with cystic fibrosis are linked to complications and medication use: the GRAMPUS-CF study

囊性纤维化成人中不同的胃肠道症状表型与并发症及药物使用相关:GRAMPUS-CF研究

2026-10-170
OAAI
Abnormalities of the distal terminal ileum in people with cystic fibrosis assessed using magnetic resonance imaging

利用磁共振成像评估囊性纤维化患者远端回肠的异常情况

2026-07-250
OAAI
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial
LANCET
IF88.5
2024-03-015
OAAI
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
2022-02-223
OAAI
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
2022-02-1116
OAAI
Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions
MBIO
IF4.7
2021-10-2628
OA
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses

shed Sabin和新型2型口服脊髓灰质炎疫苗病毒的遗传变化和神经毒力评估

2021-07-2913
OAAI
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania

在立陶宛接种灭活脊髓灰质炎病毒疫苗的儿童中,单价口服2型Sabin脊髓灰质炎病毒疫苗挑战后免疫原性和安全性的随机4期研究

2020-07-0412
OAAI
Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame

母源抗体对二价口服脊髓灰质炎疫苗免疫婴儿的灭活脊髓灰质炎疫苗免疫原性的影响: 对脊髓灰质炎根除结局的影响

2018-10-3016
OAAI
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
LANCET
IF88.5
2016-07-0165
PREAI